Immunoassays are diagnostic analytical methods that use antibodies or antigens to detect markers or analytes in biological matrices with high sensitivity/specificity. The specific binding of ... Read More
Immunoassays are diagnostic analytical methods that use antibodies or antigens to detect markers or analytes in biological matrices with high sensitivity/specificity. The specific binding of antibodies to biological targets makes them efficient methods for the detection of disease indicators. At Bioactiva there are different types of immunoassays available, based on different designs and detection mechanisms. Take a look at our Bioactiva catalog to find the immunoassay that best fits your laboratory needs where high specificity and cost-efficient analyte detection are the prime goal.
AMA-M2-G is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).
Borrelia-G is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against Borrelia burgdorferi.
The assay is a tool in the diagnosis of Lyme borreliosis.
Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi.
The assay is a tool in the diagnosis of Lyme borreliosis.
Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.
Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.
The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.